SPECIALTY TOPICS

CURRENTLY VIEWING
Colorectal Cancer

Colorectal Cancer

Innovative clinical trials designed to exploit the explosion of data on the drivers of cancer are demonstrating value as tools to explore potential signals of efficacy across tumor types, according to oncology experts. These studies have become a feature...
Read More >>

Novel Therapy May Boost Efficacy of Chemotherapy Backbone in mCRC

Novel Strategies Progress Through mCRC Pipeline

Wnt Pathway Emerges as Attractive Target in CRC

Genetic Testing Guides mCRC Treatment

Hepatic Infusion Can Convert CRC Liver Metastases to Operable State

View More Stories >>

View Conference Coverage

2019 San Antonio Breast Cancer Symposium

2019 ASH Annual Meeting

2019 International Congress of the Society for Melanoma Research

2019 State of the Science Summit on Genitourinary Cancers in Nashville

2019 State of the Science Summit on Hematologic Malignancies in Chicago

Next Steps for Wnt Research in Colorectal Cancer

Dr. Corcoran on Promising Combination Strategies With Immunotherapy in mCRC

Dr. Benson on the Ongoing Research With Immunotherapy in mCRC

Dr. Patel on Sequencing Therapy in Rectal Cancer

Dr. Eng on Unmet Needs in Early-Onset CRC

Dr. Benson on Frontline Treatment Considerations in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in I/O Therapy for mCRC

Immunotherapy in CRC

New Therapy Options for BRAF-Mutated mCRC

Management of Colorectal Cancer Metastases

TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Ongoing Treatment & Approach Advancements in mCRC

Combination Therapy Updates from ASCO 2019

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Treatment Goals in Refractory mCRC

$Treatment Goals in Refractory mCRC$
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now